CPT® Code 80355

1. Indications

The laboratory test coded as CPT® 80355 is indicated for specific clinical scenarios where monitoring of gabapentin levels is necessary. The following conditions may warrant the performance of this test:

• Seizure Disorders - Patients undergoing treatment for seizure disorders may require regular monitoring of gabapentin levels to ensure therapeutic efficacy and safety.
• Neuropathic Pain - Individuals suffering from neuropathic pain conditions, such as diabetic neuropathy and post-herpetic neuralgia, may be tested to evaluate the effectiveness of gabapentin therapy.
• Restless Leg Syndrome - Patients diagnosed with restless leg syndrome who are prescribed gabapentin may need this test to monitor drug levels and adjust dosages as necessary.

2. Procedure

The procedure for conducting the gabapentin urine test involves several key steps that ensure accurate measurement of the drug's concentration. The following procedural steps are outlined:

• Step 1: Sample Collection - A urine sample is obtained from the patient. This can be done through a random void, where the patient provides a sample at any time, or through catheterization, which involves inserting a catheter into the bladder to collect urine. The method of collection should be documented appropriately, as it may be separately reportable.
• Step 2: Sample Preparation - Once the urine sample is collected, it is prepared for analysis. This may involve processes such as centrifugation to separate components of the urine and ensure that the sample is suitable for testing.
• Step 3: Analytical Testing - The prepared urine sample is then subjected to quantitative high-performance liquid chromatography coupled with tandem mass spectrometry (HPLC-MS/MS). This sophisticated analytical technique allows for the precise quantification of gabapentin levels in the urine, providing reliable results that can be used for clinical decision-making.

3. Post-Procedure

After the completion of the gabapentin urine test, the results are typically reviewed by a healthcare professional. Depending on the findings, further actions may be taken, such as adjusting the patient's medication dosage or evaluating the need for additional therapeutic interventions. It is important for healthcare providers to communicate the results to the patient and discuss any necessary changes in treatment plans. Additionally, proper documentation of the test results and any subsequent actions taken is essential for maintaining accurate medical records and ensuring compliance with healthcare regulations.